CACNB2 Gene

CACNB2 Gene

Introduction

Cacnb2 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-gene">
<table>
<tr><th>Gene Symbol</th><td>CACNB2</td></tr>
<tr><th>Full Name</th><td>Calcium Voltage-Gated Channel Auxiliary Subunit Beta 2</td></tr>
<tr><th>Chromosomal Location</th><td>10p12.31</td></tr>
<tr><th>NCBI Gene ID</th><td>783</td></tr>
<tr><th>OMIM</th><td>600003</td></tr>
<tr><th>Ensembl ID</th><td>ENSG00000165995</td></tr>
<tr><th>UniProt ID</th><td>Q99986</td></tr>
<tr><th>Aliases</th><td>CaB2, CAB2, CCb2A</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>

Overview

The CACNB2 gene encodes the beta-2 auxiliary subunit of voltage-gated calcium channels (VGCCs), also known as CaB2 or CACNB2[@ae2004]. Beta subunits are cytoplasmic proteins that bind to the alpha-1 subunit through a high-affinity interaction and play critical roles in modulating channel trafficking, gating, and voltage dependence[@e1998]. CACNB2 is expressed in various tissues including heart, brain, and endocrine cells, and is associated with multiple neurological and cardiovascular disorders[@j2019].

Gene Structure and isoforms

CACNB2 Gene

Introduction

Cacnb2 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-gene">
<table>
<tr><th>Gene Symbol</th><td>CACNB2</td></tr>
<tr><th>Full Name</th><td>Calcium Voltage-Gated Channel Auxiliary Subunit Beta 2</td></tr>
<tr><th>Chromosomal Location</th><td>10p12.31</td></tr>
<tr><th>NCBI Gene ID</th><td>783</td></tr>
<tr><th>OMIM</th><td>600003</td></tr>
<tr><th>Ensembl ID</th><td>ENSG00000165995</td></tr>
<tr><th>UniProt ID</th><td>Q99986</td></tr>
<tr><th>Aliases</th><td>CaB2, CAB2, CCb2A</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>

Overview

The CACNB2 gene encodes the beta-2 auxiliary subunit of voltage-gated calcium channels (VGCCs), also known as CaB2 or CACNB2[@ae2004]. Beta subunits are cytoplasmic proteins that bind to the alpha-1 subunit through a high-affinity interaction and play critical roles in modulating channel trafficking, gating, and voltage dependence[@e1998]. CACNB2 is expressed in various tissues including heart, brain, and endocrine cells, and is associated with multiple neurological and cardiovascular disorders[@j2019].

Gene Structure and isoforms

The CACNB2 gene spans approximately 45 kb on chromosome 10p12.31 and consists of 13 exons encoding multiple protein isoforms. The beta subunit proteins share a conserved structure consisting of:

• SH3 domain (SRC homology 3): Located at the N-terminus, involved in protein-protein interactions
• Kinase domain (PKA target): Contains serine/threonine residues phosphorylated by protein kinase A
• VDID (Von Willebrand factor type A) domain: The main protein-binding domain that interacts with the alpha-1 subunit
• C-terminal tail: Contains additional regulatory sites for phosphorylation and protein interactions

Protein Function

Channel Trafficking

The beta-2 subunit plays a crucial role in facilitating the proper localization of calcium channels to the plasma membrane[@l2011]. The VDID domain binds to a conserved motif in the alpha-1 subunit (the AID - alpha-interacting domain), which is essential for:

• Forward trafficking from the endoplasmic reticulum to the plasma membrane
• Retention of channels at the cell surface
• Prevention of channel degradation

Gating Modulation

Beta subunits alter the activation and inactivation kinetics of calcium channels[@j2016]:

• Activation: β2 subunits typically accelerate activation
• Inactivation: They modulate both voltage-dependent and calcium-dependent inactivation
• Recovery: They affect the rate of recovery from inactivation

Voltage Dependence

The beta-2 subunit shifts the voltage dependence of activation and inactivation:

• Shifts the activation curve to more negative voltages (facilitating opening)
• Alters the inactivation curve depending on isoform
• Affects the window current properties

Tissue Distribution and Expression

| Tissue | Expression Level | Primary Function |
|--------|-----------------|------------------|
| Heart (cardiac myocytes) | High | L-type Ca²⁺ current (I_Ca-L), cardiac contraction |
| Brain (cortex) | Moderate | Synaptic transmission, neuronal excitability |
| [Hippocampus](/brain-regions/hippocampus) | Moderate | Learning and memory, synaptic plasticity |
| Cerebellum | Moderate | Motor coordination, cerebellar Purkinje cell function |
| Pancreas (β-cells) | Moderate | Insulin secretion, glucose homeostasis |
| Smooth muscle | Moderate | Vascular tone, vasoconstriction |
| Retina | Low | Photoreceptor function |

Disease Associations

Alzheimer's Disease

Calcium dysregulation is a hallmark of [Alzheimer's disease](/diseases/alzheimers-disease) (AD), and CACNB2 dysfunction may contribute to disease pathogenesis through multiple mechanisms[@k2015]:

• Synaptic plasticity: Beta-2 subunits modulate L-type calcium channels important for synaptic plasticity and memory formation
• Calcium homeostasis: Altered channel function can lead to intracellular calcium overload
• Amyloid interaction: Some studies suggest [amyloid-beta](/proteins/amyloid-beta) peptides may interact with VGCCs
• [Tau](/proteins/tau) pathology: Calcium dysregulation may exacerbate [tau](/proteins/tau) phosphorylation and aggregation

Bipolar Disorder and Schizophrenia

CACNB2 is a genome-wide association study (GWAS) risk gene for both bipolar disorder and schizophrenia[@international2009]:

• Bipolar disorder: Multiple GWAS have identified CACNB2 variants associated with bipolar disorder risk
• Cognitive dysfunction: CACNB2 variants may affect prefrontal cortical function
• Signal transduction: The beta-2 subunit interacts with cAMP/PKA signaling pathways implicated in mood disorders

Epilepsy

Some CACNB2 variants are associated with seizure susceptibility[@r2011]:

• Altered neuronal excitability due to changed calcium channel gating
• Impaired regulation of neurotransmitter release
• Potential therapeutic implications for anti-epileptic drug development

Spinocerebellar Ataxia

Rare CACNB2 variants may contribute to cerebellar dysfunction:

• Impaired Purkinje cell function
• Altered calcium signaling in cerebellar [neurons](/entities/neurons)
• Potential contribution to ataxia symptoms

Cardiovascular Disorders

Brugada Syndrome

CACNB2 loss-of-function variants cause Brugada syndrome, a genetic disorder characterized by distinctive ECG changes and increased risk of sudden cardiac death[@p2007]:

• Reduced L-type calcium current (I_Ca-L) in cardiac myocytes
• ST-segment elevation in right precordial leads
• Increased risk of ventricular arrhythmias

Long QT Syndrome

Some CACNB2 variants affect cardiac repolarization:

• Altered calcium channel function
• Prolonged QT interval on ECG
• Risk of torsades de pointes

Other Cardiovascular Conditions

• Atrial fibrillation: GWAS-identified risk variants
• Sudden cardiac death: Associated with loss-of-function variants
• Heart failure: Altered calcium handling in cardiac dysfunction

Therapeutic Targeting

Calcium channel blockers targeting L-type channels have been developed for cardiovascular applications[@j2020]:

| Drug Class | Examples | Mechanism | Clinical Use |
|------------|----------|-----------|--------------|
| Dihydropyridines | Nifedipine, Amlodipine | Block L-type channels | Hypertension, angina |
| Phenylalkylamines | Verapamil | Block L-type channels | Arrhythmia, angina |
| Benzothiazepines | Diltiazem | Block L-type channels | Hypertension, angina |

Neurological Applications

Potential neurological therapeutic approaches include:

• Anti-epileptic drugs: Modulating neuronal calcium currents
• Neuroprotective strategies: Preventing calcium-induced neuronal death
• Cognitive enhancement: Targeting synaptic calcium signaling

Key Publications

Background

The study of Cacnb2 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• [NCBI Gene: CACNB2](https://www.ncbi.nlm.nih.gov/gene/783)
• [UniProt: Q99986](https://www.uniprot.org/uniprot/Q99986)
• [OMIM: 600003](https://www.omim.org/entry/600003)
• [Ensembl: ENSG00000165995](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000165995)

References